Semaglutide, and similar medications, is a glucagon-like peptide-1 (GLP-1) receptor agonist
Lean loss is a normal consequence of large, rapid weight loss on any incretin drug
For iatrogenic hypercortisolism (corticosteroid medication): gradual dose reduction under medical supervision is essential, as abrupt cessation can precipitate adrenal crisis
As the patient titrates up to clinical maintenance doses (such as 1.7 mg or 2.4 mg per week), the pharmacy cost increases
To view or add a comment, sign in Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial To view or add a comment, sign in 2,859 followers